Icatibant is a synthetic decapeptide that functions as a selective bradykinin B2 receptor antagonist, indicated for the symptomatic treatment of acute attacks of hereditary angioedema in adults with C1-esterase-inhibitor… Read more

![Chemical structure of ((2S,3aS,7aS)-1-((3S,6R)-3-((S)-2-(2-((2R,4R)-1-(N2-(D-Arginyl)-Nd-nitroso-L-arginyl-L-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanamido)-4-oxo-3,4,7,11b-tetrahydro-2H,6H-[1,3]oxazino[2,3-a]isoquinoline-6-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS7aS-1-3S6R-3-S-2-2-2R4R-1-N2-D-Arginyl-Nd-nitroso-L-arginyl-L-prolyl-4-hydroxypyrrolidine-2-carboxamidoacetamido-3-thiophen-2-ylpropanamido-4-oxo.png&w=3840&q=75)
![Chemical structure of ((2S,3aS,7aS)-1-((3S,6R)-3-((S)-2-(2-((2S,4R)-1-(D-Arginyl-L-arginyl-L-prolyl)-4-hydroxypyrrolidine-2-carboxamido)acetamido)-3-(thiophen-2-yl)propanamido)-4-oxo-3,4,7,11b-tetrahydro-2H,6H-[1,3]oxazino[2,3-a]isoquinoline-6-carbonyl)octahydro-1H-indole-2-carbonyl)-L-arginine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3aS7aS-1-3S6R-3-S-2-2-2S4R-1-D-Arginyl-L-arginyl-L-prolyl-4-hydroxypyrrolidine-2-carboxamidoacetamido-3-thiophen-2-ylpropanamido-4-oxo-34711b-tetrah.png&w=3840&q=75)















































Icatibant is a synthetic decapeptide that functions as a selective bradykinin B2 receptor antagonist, indicated for the symptomatic treatment of acute attacks of hereditary angioedema in adults with C1-esterase-inhibitor deficiency. The management of this drug requires precise analytical oversight to ensure safety and therapeutic efficacy throughout its lifecycle. To support these rigorous requirements, this category provides a comprehensive selection of Icatibant reference standards, impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for critical tasks such as impurity profiling, routine quality control, and the validation of analytical methods including HPLC and LC-MS. By providing high-quality benchmarks for the identification and quantification of process-related impurities and degradation products, these reference materials enable accurate method development and ensure compliance with global regulatory standards for drug quality and purity.